12:55 AM EDT, 10/27/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lift our target by $10 to $320, valuing CB at 11.3x our newly initiated 2027 operating EPS estimate of $28.20 and at 12x our 2026 EPS of $26.15, vs. CB's three-year avg. forward multiple of 12.3x and a peer avg. of 13x. We lift our 2025 EPS by $1.93 to $23.74, after CB posted Q3 EPS of $7.49 vs. $5.72, significantly better than our $5.56 estimate and the $6.15 consensus view, amid improved underlying claim trends and 63% lower catastrophe losses (of $285M vs. $765M), evidenced by the Q3 P-C combined ratio of 81.8% vs. 87.7%. While Q3 "cat" claims were unusually low, we remain positive on CB's overall underwriting results, despite a more competitive industry-wide pricing environment. We see net written premiums +5%-8% in 2025 and see a similar rise in operating revenue growth on an expected 5%-7% rise in earned premiums and 8%-10% higher investment income. We view CB as a top tier underwriter and view the shares, currently trading at 10.8x our 2026 EPS estimate, as undervalued vs. peer and historical avg.